Delivery Order SPE2DB20D3304-SPE2DB25FW8V6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Adderall 10 mg tablets in quantities of 100 units, with a ceiling value of $1,899.03. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 14, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Adderall 10 mg tablets in quantities of 100 units. This firm fixed-price delivery order has a ceiling value of $35,426.45 and is scheduled for completion by August 5, 2025. The contract represents a non-set-aside, competitively awarded action and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Adderall 20 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $7,744.40 and is structured as a firm fixed-price delivery order, with an ultimate completion date of September 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Adderall 20 mg tablets (100-count units) with a ceiling value of $1,932.81. This firm fixed-price, non-set-aside delivery order is scheduled for completion by July 29, 2025, with performance at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a continuation of the vendor's role as a critical pharmaceutical supplier to federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,798.06 to AmerisourceBergen Drug Corp for the supply of Adderall 20 mg tablets (100 count units). This firm fixed-price delivery order, awarded on April 24, 2025, represents a non-set-aside competitive procurement with an ultimate completion date of April 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Adderall 15 mg tablets (100 count) with a ceiling value of $5,233.57. This firm fixed-price delivery order, with an ultimate completion date of September 11, 2025, represents a single pharmaceutical supply transaction under AmerisourceBergen's existing contract vehicle with DLA. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. No...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Adderall 10 mg tablets in quantities of 100, with a ceiling value of $7,054.28. This non-set-aside, firm fixed-price delivery order is scheduled for completion by August 28, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the federal medical supply chain. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Adderall 10 mg tablets in quantities of 100, with a ceiling value of $3,012.75 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of September 9, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Adderall 5 mg tablets in quantities of 100 units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,266.02 and an ultimate completion date of September 4, 2025. The contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Adderall 15 mg tablets (100-count units) with a ceiling value of $2,083.55. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is set for ultimate completion by September 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child...
- SPE2DB20D3304Indefinite Delivery Contract
- SPE2DB20D3304-SPE2DB25FW8V6Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Adderall 20 mg tablets (100-count units) with a ceiling value of $9,535.69 and an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for controlled pharmaceutical products supports the ongoing medical supply requirements of the federal defense healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.5k | 8/29/25 |